NCT03858075View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics, and Food Effect of BLU-782 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

September 11, 2019

Study Completion Date

September 11, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

BLU-782

oral capsules

DRUG

Placebo

oral capsules

DRUG

BLU-782 taken with food

oral capsules

Trial Locations (1)

68502

Undisclosed, Lincoln

Sponsors
All Listed Sponsors
lead

Blueprint Medicines Corporation

INDUSTRY

NCT03858075 - Safety, Tolerability, Pharmacokinetics, and Food Effect of BLU-782 in Healthy Adults | Biotech Hunter | Biotech Hunter